✦ LIBER ✦

A First in Human Phase 1 Study of CG0070, a GM-CSF Expressing Oncolytic Adenovirus, for the Treatment of Nonmuscle Invasive Bladder Cancer

✍ Scribed by Burke, James M.; Lamm, Donald L.; Meng, Maxwell V.; Nemunaitis, John J.; Stephenson, Joseph J.; Arseneau, James C.; Aimi, Junko; Lerner, Seth; Yeung, Alex W.; Kazarian, Troy; Maslyar, Daniel J.; McKiernan, James M.

Book ID: 121433613
Publisher: Lippincott Williams and Wilkins
Year: 2012
Tongue: English
Weight: 773 KB
Volume: 188
Category: Article
ISSN: 0022-5347
DOI: 10.1016/j.juro.2012.07.097

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

4538 POSTER Phase II study of concurrent

4538 POSTER Phase II study of concurrent chemoradiotherapy (CCRth) for bladder preservation in the treatment of muscle invasive bladder cancer

✍ Mohamed El Taher, A.; Mekawy, M.; Shehata Eid, S.; El Din Mostafa, H.G.; Abdel A 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 58 KB

Chemotherapy with gemcitabine, cisplatin

Chemotherapy with gemcitabine, cisplatin, and docetaxel in the treatment for patients with muscle-invasive bladder cancer: a multicenter phase II study of the Hellenic Oncology Research Group (HORG)

✍ Ioannis Boukovinas; Nikolaos Androulakis; Nikolaos Kentepozidis; Aris Polyzos; P 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 218 KB

Use of the folinic acid/5-fluorouracil/i

Use of the folinic acid/5-fluorouracil/irinotecan (FOLFIRI 1) regimen in elderly patients as a first-line treatment for metastatic colorectal cancer: a Phase II study

✍ Eric François; Jean-François Berdah; Emmanuel Chamorey; Gérard Lesbats; Eric Tei 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 286 KB